Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAOK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ALG10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTHLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EVI5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRFBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAZ1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on